Clinical Trial Update: Identification of BCR::ABL1 Mutations by Digital PCR in CML [NA]

View source ↗

Summary

A clinical trial update describes using digital PCR to identify BCR-ABL1 mutations in chronic myeloid leukemia. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Myeloid Leukemia (CML) | NA | Status: NOT_YET_RECRUITING